ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,294.10
-0.42%
S&P ASX All Technology
3,845.90
-0.28%
Brent Oil
79.285
3.07%
US Dollar vs AUD
1.6276
0.74%
Bitcoin
94,737.27
2.52%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Qualigen Therapeutics Inc (QLGN)

  7. Qualigen Therapeutics Inc (QLGN) News

QLGN

Qualigen Therapeutics (QLGN)

Qualigen Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:QLGN
DateTimeSourceHeadlineSymbolCompany
27/12/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
20/12/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:QLGNQualigen Therapeutics Inc
11/12/202406:27Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:QLGNQualigen Therapeutics Inc
06/12/202401:00GlobeNewswire Inc.Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity RequirementNASDAQ:QLGNQualigen Therapeutics Inc
26/11/202409:00GlobeNewswire Inc.Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)NASDAQ:QLGNQualigen Therapeutics Inc
23/11/202409:28Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:QLGNQualigen Therapeutics Inc
22/11/202409:10Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:QLGNQualigen Therapeutics Inc
22/11/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
20/11/202401:00GlobeNewswire Inc.Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred SharesNASDAQ:QLGNQualigen Therapeutics Inc
16/11/202408:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QLGNQualigen Therapeutics Inc
15/11/202408:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QLGNQualigen Therapeutics Inc
14/11/202409:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
09/11/202409:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
02/11/202407:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
02/11/202400:00GlobeNewswire Inc.Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024NASDAQ:QLGNQualigen Therapeutics Inc
30/10/202407:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
25/10/202408:06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:QLGNQualigen Therapeutics Inc
23/10/202407:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
18/10/202407:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QLGNQualigen Therapeutics Inc
10/10/202407:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
10/10/202407:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:QLGNQualigen Therapeutics Inc
27/09/202407:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
27/09/202407:10GlobeNewswire Inc.Qualigen Therapeutics, Inc. Announces management changes.NASDAQ:QLGNQualigen Therapeutics Inc
21/09/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
20/09/202423:00GlobeNewswire Inc.Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings PanelNASDAQ:QLGNQualigen Therapeutics Inc
10/09/202407:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
07/09/202407:00GlobeNewswire Inc.Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)NASDAQ:QLGNQualigen Therapeutics Inc
07/09/202406:30GlobeNewswire Inc.Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public OfferingNASDAQ:QLGNQualigen Therapeutics Inc
07/09/202405:46Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:QLGNQualigen Therapeutics Inc
05/09/202423:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:QLGN

Your Recent History

BOV
BITB39
BlackRock Institutional ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads